Antibiotic Stewardship at transitions of care: identifying opportunities for antibiotic optimization
Antimicrobial Stewardship & Healthcare Epidemiology · 2026 · 6 (1)
DOI: 10.1017/ash.2026.10305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 25.03.2026. Verfasst von Corey Johnson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cone Health Moses Cone Hospital, Greensboro, USA. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We conducted a cross-sectional study to identify the frequency of optimized oral antibiotic regimens at transitions of care (TOC) in patients diagnosed with respiratory, urinary tract, or skin structure infections. An optimal regimen was identified in 62.5% of patients at TOC, highlighting opportunities for antimicrobial stewardship interventions at TOC.
Autor:innen und Institutionen
- Cone Health Moses Cone Hospital, Greensboro, USA.
- University of Pittsburgh Medical Center East, Pittsburgh, USA.
- University of Virginia Health System, Charlottesville, USA.
ORCID-Profile: Corey Medler
Zitieren
APA
Johnson, C., Thomas, J., Valanejad, S., & Medler, C. (2026). Antibiotic Stewardship at transitions of care: identifying opportunities for antibiotic optimization. Antimicrobial Stewardship & Healthcare Epidemiology, 6(1). https://doi.org/10.1017/ash.2026.10305
Vancouver
Johnson C, Thomas J, Valanejad S, Medler C. Antibiotic Stewardship at transitions of care: identifying opportunities for antibiotic optimization. Antimicrobial Stewardship & Healthcare Epidemiology. 2026;6(1). doi:10.1017/ash.2026.10305
BibTeX
@article{Johnson2026,
author = {Johnson, Corey and Thomas, Jenni and Valanejad, Sara and Medler, Corey},
title = {Antibiotic Stewardship at transitions of care: identifying opportunities for antibiotic optimization},
journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
year = {2026},
volume = {6},
number = {1},
doi = {10.1017/ash.2026.10305}
}
EUVIMED